Anti-GLSK/ GLS/ AAD20 functional antibody

Anti-GLSK/ GLS/ AAD20 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to GLS/GLS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-TA039-Ab-1/ GM-Tg-hg-TA039-Ab-2Anti-Human GLS monoclonal antibodyHuman
GM-Tg-rg-TA039-Ab-1/ GM-Tg-rg-TA039-Ab-2Anti-Rat GLS monoclonal antibodyRat
GM-Tg-mg-TA039-Ab-1/ GM-Tg-mg-TA039-Ab-2Anti-Mouse GLS monoclonal antibodyMouse
GM-Tg-cynog-TA039-Ab-1/ GM-Tg-cynog-TA039-Ab-2Anti-Cynomolgus/ Rhesus macaque GLS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-TA039-Ab-1/ GM-Tg-felg-TA039-Ab-2Anti-Feline GLS monoclonal antibodyFeline
GM-Tg-cang-TA039-Ab-1/ GM-Tg-cang-TA039-Ab-2Anti-Canine GLS monoclonal antibodyCanine
GM-Tg-bovg-TA039-Ab-1/ GM-Tg-bovg-TA039-Ab-2Anti-Bovine GLS monoclonal antibodyBovine
GM-Tg-equg-TA039-Ab-1/ GM-Tg-equg-TA039-Ab-2Anti-Equine GLS monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-TA039-Ab-1/ GM-Tg-hg-TA039-Ab-2; GM-Tg-rg-TA039-Ab-1/ GM-Tg-rg-TA039-Ab-2;
GM-Tg-mg-TA039-Ab-1/ GM-Tg-mg-TA039-Ab-2; GM-Tg-cynog-TA039-Ab-1/ GM-Tg-cynog-TA039-Ab-2;
GM-Tg-felg-TA039-Ab-1/ GM-Tg-felg-TA039-Ab-2; GM-Tg-cang-TA039-Ab-1/ GM-Tg-cang-TA039-Ab-2;
GM-Tg-bovg-TA039-Ab-1/ GM-Tg-bovg-TA039-Ab-2; GM-Tg-equg-TA039-Ab-1/ GM-Tg-equg-TA039-Ab-2
Products NameAnti-GLS monoclonal antibody
Formatmab
Target NameGLS
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GLS benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-TA039-Ag-1Recombinant multi-species GLSK/ GLS/ AAD20 protein
    ORF Viral VectorvGMLV000116human GLS Lentivirus particle
    ORF Viral VectorpGMLV000116human GLS Lentivirus plasmid


    Target information

    Target IDGM-TA039
    Target NameGLS
    Gene ID2744,14660,24398,693520,488448,101080395,525335,100069617
    Gene Symbol and Synonyms6330442B14,AAD20,B230365M23Rik,CASGID,DEE71,EIEE71,GAC,GAM,GDPAG,GLS,GLS1,Glut,KGA,RATGLUT
    Uniprot AccessionO94925,P13264
    Uniprot Entry NameGLSK_HUMAN,GLSK_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000115419
    Target ClassificationN/A

    The target: GLS, gene name: GLS, also named as AAD20, GAC, GAM1, KGA, GLS. This gene encodes the K-type mitochondrial glutaminase. The encoded protein is an phosphate-activated amidohydrolase that catalyzes the hydrolysis of glutamine to glutamate and ammonia. This protein is primarily expressed in the brain and kidney plays an essential role in generating energy for metabolism, synthesizing the brain neurotransmitter glutamate and maintaining acid-base balance in the kidney. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.